Watch our October 2020 briefing, Counterfeit Medicine: Crime and Policy 2020, a summary of the major cases we've seen this year, the trends that worry us, and current drug supply chain policy issues, followed by a ten minute Q&A session with PSM Executive Director Shabbir Imber Safdar.
See the latest news on Federal rulemaking
and follow dangerous importation experiments at the Federal and state level: Colorado, Connecticut, Florida, Maine, New Hampshire, New Mexico, Vermont
Today, PhRMA, The Partnership for Safe Medicines and Council for Affordable Health Coverage initiated litigation in the U.S. District Court for the District of Columbia challenging action by HHS and FDA permitting pharmacists and wholesalers, pursuant to state-sponsored programs, to import certain prescription drugs from Canada into the United States without drug manufacturers’ authorization or oversight.
In PSM’s round-up this week: Government authorities take legal action against COVID scammers; an insurance broker (allegedly) decided to open his own unlicensed pharmacy; ongoing counterfeit medicine news, and more.
In PSM’s round-up this week: An analysis of New Mexico’s draft drug importation plan, reports on COVID-19 fraud, and this week in counterfeit medicine news.
The state of New Mexico released a draft of its Canadian drug importation plan. PSM analyzed the plan, paying particular attention to concerns pharmacists might have about how drug importation might affect their patients and business…
In PSM’s round-up this week: FDA and FTC warnings over fake COVID-19 treatments and fraud, as well as fake medicine news in seven U.S. states, Canada and Cambodia.
News of the Week
Subscribe on YouTube for more.
Report suspected fraud to the FDA’s Health Fraud Program or email FDA-COVID-19-Fraudulent-Adopt our Covid Safety campaign!
Post our one pager to your website and to social media. Use the hashtag #covidscams to help raise awareness of criminals using the crisis to prey on people.
